ROR-gamma T

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameROR-gamma T
Drug Alias NameROR gamma t modulator (Evommune)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear receptor ROR-gamma modulators
TargetsNuclear receptor ROR-gamma
Therapy Area/IndicationsGraft vs Host DiseasePsoriasisRosacea +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDermira Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvommune Inc
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseasePsoriasisRosacea +[5] 

Other Information

ATC CodeN/A
Related LinksN/A